Fifteen mature meadow voles (Microtus pennsylvanicus) were assigned to each of four diets: 1) basal; 2) basal + .001% pilocarpine (PLCN); 3) basal + .01% PLCN; 4) basal + .10% PLCN in a completely randomized design to measure the effect of PLCN on liver, kidney and parotid gland histopathology and feed intake. Meadow voles were fed each treatment for 14 d prior to euthanasia. Serum glutamic o• transaminase, glutamic pyruvate transaminase and alkaline phosphatase levels were unaffected by dietary PLCN. Liver fresh weight tended to decrease with PLCN treatment, but kidney weight was not consistently affected. Parotid gland fresh weight decreased by 31% as the dietary level of PLCN increased from 0 to .10%. One of 15 voles on the control treatment died. Twelve of the remaining 14 voles showed no histopathoiogical changes in the organs studied, but one showed segmental cystic dilation of some convoluted tubules and one showed chronic cortical interstitial nephritis. One vole of the 15 on the .001% PLCN treatment died. Eleven of the 14 remaining voles showed no histopathoiogical changes in the organs studied, while two voles showed segmental cystic dilation of some convoluted tubules and one showed slight hydropic degeneration of hepatocytes. There was no mortality among voles fed .0196 PLCN. Nine of the 15 voles showed no histopathological changes in the organs, while four showed slight hydropic degeneration of hepatocytes and one showed segmental cystic dilation of some convoluted tubules. Three of 15 voles died while fed .10% PLCN. The remaining 12 voles showed no histopathologlcal changes in the above-mentioned organs, although three voles showed slight hydropic degeneration of hepatocytes.
Introduction
Pilocarpine (PLCN) is a parasympathomimetic alkaloid capable of stimulating salivation in most mammals (Goodman and Gilman, 1980) . Wiedmeier et al. (1987) have shown that PLCN is capable of stimulating saliva flow in cattle fed high-cereal grain, chopped-forage diets, thereby stabilizing rumen ecology and increasing nutrient digestibility. The effect of PLCN on the histopathology of liver, kidney and parotid glands was not investigated by Wiedmeier et al. (1987) . Before PLCN can be used on a practical basis to improve cattle performance, these effects must be ascertained.
Meadow voles (Microtus pennsylvanicus) have been used successfully as models for ruminants in feed quality, digestibility, and production studies (Shenk et al., 1975) . Meadow voles have also proven to be useful in aniz Dept. of Anita., Dairy and Vet. Sci. Received July 18, 1986. Accepted April 6, 1987. mal bioassays of feed palatability (Kendall and Sherwood, 1975) and toxicity studies (Gustine et al., 1974) , correlating well to ruminants. Although they are monogastric, they have an esophageal, pregastric pouch with twice the capacity of the gastric stomach, the pH of which is 6.5 to 7.0 (Keys and Van Soest, 1970) . The native diet is grass but they are capable of consuming diets consisting of up to 70% nonstructural carbohydrates without ill effects (Shenk et al., 1970) .
The purpose of this study was to evaluate the effects of orally administered PLCN on serum enzymes, organ weights and histopathology of meadow voles.
Materials and Methods
Fifteen mature, female meadow voles (Microtus pennsylvanicus) approximately 30 d of age were weighed and assigned to each of four diets (table 1) in a completely randomized design. Diets were fed as a total mixed meal, the ingredients being ground to pass through a 1-mm screen. Voles were individually housed in a 60-cage stainless steel battery with mesh 734.
J. Anim. Sci. 1987. 65:734-737 floors. Cages were equipped with food consumption jars, water tubes and cotton bedding. Voles were housed in a room with relative humidity of 38 to 40%, temperature of 18 C and day length of 12 h.
Voles and food consumption jars were weighed at O, 7 and 14 d after initiation of the study. On d 14, voles were euthanized using CO~. Blood samples were immediately withdrawn by cardiac puncture. Blood samples from two voles were pooled to provide adequate volume for serum glutamic oxaloacetate transaminase (SGOT), glutamic pyruvate transaminase (SGPT) and alkaline phosphatase (ALKP) analysis 2. Kidneys, liver and parotid glands were then removed, blotted, weighed and fixed in 50% formalin solution. Fixed samples were embedded in paraffin and sliced with a microtome at 6 /am. Slices were stained with hematoxylin eosin and examined for histopathology.
Data were analyzed using a model for a completely randomized design for unbalanced data with four treatments and 12 and 15 observations per treatment. Means were separated by the Duncan multiple range test utilizing the harmonic mean of the numbers of observations per treatment (Snedecor and Cochran, 1967) . 2System 103, Gilford Scientific, 132 Artino, St., Oberlin, OH 44074.
Results and Discussion
Levels of SGOT, SGPT, and ALKP were not affected by PLCN treatment (P>.05; table 2). Since it was necessary to obtain as large a blood sample as possible from each vole, there was considerable hemolysis that resulted in elevated serum levels of these enzymes with the analytical method used. However, there appeared to be no extensive tissue damage in the voles as a result of PLCN treatment, as indicated by serum enzyme levels.
The effects of PLCN treatment on liver, kidney, and parotid gland weights and feed intake are presented in table 3. Liver weight tended to decrease with PLCN treatment but there was not a dose response. Liver weight was reduced below controls (P<.05) by .001% PLCN. Kidney weight was reduced (P<.05) by .01% PLCN compared with .001 and .10% PLCN. Parotid gland weight tended to decrease with .001 and .01% dietary PLCN and was reduced by 31% by .10% dietary PLCN treatment. The reason why some doses of PLCN had an effect on organ weights while others did not is difficult to deduce from the data collected in this study, but there was no apparent tissue damage indicated by SGOT, SGPT, or ALKP levels in blood serum. Treatment with PLCN has been shown to initially increase pancreas weight, but prolonged treatment resulted in the opposite effect (Sturgess and Reid, 1973) . But PLCN treatment initially decreased thymus weight, while prolonged treatment showed normal thymus weights (Sturgess and Reid, 1973) . Treatment with PLCN obviously has different effects on different glands through time. In animals treated with PLCN, glands ~at have primarily a secretory function such as the pancreas and partoids have shown initial increases in weight due to hypertrophy, but continued treatment has shown reduction in weight, probably due to synthesis not keeping up with secretion (Baskerville et al., 1976; Sturgess and Reid, 1973) . The effects of PLCN on nonsecretory glands such as thymus, liver and spleen have been variable. Nagai et al. (1971) showed that carbachol, a parasympathomimetic agent similar in effect to PLCN, depressed liver gluconeogenesis while activating glycolysis. Sturgess and Reid (1973) measured no effect of PLCN on liver or spleen, but, as already mentioned, thymus weight was initially reduced and later returned to normal.
Feed intake was increased when PLCN was administered as .001% of diet (table 3) . Increased saliva flow and increased rate of gastrointestinal contractions in voles fed .001% PLCN could account for increased intake. Increased flow rates of digesta have been measured in cattle administered PLCN orally (Wiedmeier et al., 1987) . In the meadow vole study, higher levels of PLCN had no effect on intake, possibly due to over-stimulation of the parotid gland with eventual exhaustion. Parotid weight was decreased at the highest level of PLCN (table 3) . Therefore, results indicate that overstimulation of the parotid gland is possible and could be of concern when feeding pitocarpine orally to ruminants.
Data on the effects of PLCN on mortality and liver, kidney and parotid gland histopathology are presented in table 4. No effect of PLCN was observed conclusively. aslight hydropic degeneration of hepatoeytes.
boccasional segmental cystic dilation of a convoluted tubule in the cortex and degeneration of tubular epithelial cells.
In conclusion, levels of PLCN from .01 to .10% resulted in a decrease in parotid gland weight. At the .001% level, PLCN increased feed intake. Data presented in this study suggest that levels of orally administed PLCN up to .01% of diet can be used without damage to liver, kidney or parotid tissues.
